Coverage
-
July 13, 2017
A New Jersey federal judge on Wednesday denied EpiPen maker Mylan's motion to move to Kansas a lawsuit alleging that it offered rebates to insurers that refused to cover a competing Sanofi-Aventis epinephrine auto-injector.
1 other articles on this case.
View all »